GTG — Genetic Technologies Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual income statement for Genetic Technologies, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | R2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 6.79 | 8.69 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 3.78 | 4.35 | — | — | — |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 14.4 | 21 | 6.26 | 0.412 | 0.429 |
| Operating Profit | -7.57 | -12.3 | -6.26 | -0.412 | -0.429 |
| Total Net Non Operating Interest Income / Expense | |||||
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -7.16 | -11.9 | -6.19 | -0.43 | -0.429 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -7.13 | -11.8 | -6.19 | -0.43 | -0.429 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -7.13 | -11.8 | -12 | -1.46 | -0.429 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -7.13 | -11.8 | -12 | -1.46 | -0.429 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.074 | -0.098 | -0.045 | -0.008 | -0 |